Werba Branlyn E, Hobbie Wendy, Kazak Anne E, Ittenbach Richard F, Reilly Anne F, Meadows Anna T
Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104-4399, USA.
Pediatr Blood Cancer. 2007 Jun 15;48(7):673-7. doi: 10.1002/pbc.21184.
To develop and validate a method of classifying the intensity of pediatric oncology treatments using four operationally defined categories of treatment intensity.
An earlier version of a rating scale, the intensity of treatment rating (ITR), was revised and validated in two phases. In the Scale Construction phase, three criterion raters revised the ITR items based on consensus and item agreement data from pediatric oncologist raters (N = 15). In the Scale Validation phase, the new ITR-2 items were validated using a second set of pediatric oncologists external to our institution (N = 12). In addition, a third group of raters (N = 16), was employed to assess inter-rater reliabilities for 12 patients at varying levels of treatment intensities.
Agreement between criterion ratings and the median of external raters for all 34 items on the ITR-2 was very high (r = 0.95, range 0.71-0.91). When the ITR-2 was used to rate 12 patient examples, the inter-rater agreement among pediatric oncologists was also very high (median agreement between criterion-rater pairs: r = 0.87; overall relatedness among 16 raters: r(ICC) = 0.83).
The revised ITR Scale 2.0 (ITR-2) is a valid and reliable scale for classifying the intensity of pediatric oncology treatments.
开发并验证一种使用四个操作性定义的治疗强度类别对儿科肿瘤治疗强度进行分类的方法。
对一个评级量表的早期版本——治疗强度评级(ITR)进行了两个阶段的修订和验证。在量表构建阶段,三名标准评分者根据儿科肿瘤学家评分者(N = 15)的共识和项目一致性数据对ITR项目进行了修订。在量表验证阶段,使用我们机构外部的另一组儿科肿瘤学家(N = 12)对新的ITR-2项目进行了验证。此外,还聘请了第三组评分者(N = 16)来评估12名处于不同治疗强度水平的患者的评分者间信度。
ITR-2上所有34个项目的标准评分与外部评分者中位数之间的一致性非常高(r = 0.95,范围0.71 - 0.91)。当使用ITR-2对12个患者实例进行评分时,儿科肿瘤学家之间的评分者间一致性也非常高(标准评分者对之间的中位数一致性:r = 0.87;16名评分者之间的总体相关性:r(ICC) = 0.83)。
修订后的ITR量表2.0(ITR-2)是一种用于分类儿科肿瘤治疗强度的有效且可靠的量表。